Literature DB >> 30363525

Unawareness of Hyposmia in Elderly People With and Without Parkinson's Disease.

Holly A Shill1,2, Joseph G Hentz3, John N Caviness3, Erika Driver-Dunckley3, Sandra Jacobson1,2, Christine Belden1, Marwan N Sabbagh1,2, Thomas G Beach1, Charles H Adler3.   

Abstract

BACKGROUND: Hyposmia is common in Parkinson's disease (PD) and is also observed with normal aging. It can be ascertained through objective testing, but it is unclear whether patients are aware of deficits and whether this has implications for cognitive status.
METHODS: Subjects in the Arizona Study of Aging and Neurodegenerative Disorders were studied with annual motor and cognitive testing with objective smell testing (University of Pennsylvania Smell Identification Test; UPSIT) done every third year beginning in 2002. Those with a baseline UPSIT <25th percentile (hyposmia) were studied for presence of unawareness of hyposmia and cognitive status.
RESULTS: There were 75 subjects with PD and 143 nonparkinsonian controls with hyposmia. Lack of awareness of hyposmia was present in 16% of PD subjects and 47% of those without PD. In PD, there was no increase in unawareness in PD with dementia. In non-PD controls, unawareness was correlated with presence of dementia. Unawareness of hyposmia correlated most strongly with the neuropsychiatric tests of learning and memory. In controls without dementia or PD, 48% were unaware.
CONCLUSIONS: Querying patients about anosmia might be useful in parkinsonian disorders without objective testing. However, in elderly controls, it should be followed by objective testing and lack of awareness has implications for worsened cognitive status.

Entities:  

Keywords:  Alzheimer's; Parkinson's disease; biomarker; olfaction; screening

Year:  2015        PMID: 30363525      PMCID: PMC6178706          DOI: 10.1002/mdc3.12220

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  26 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Association of olfactory dysfunction with risk for future Parkinson's disease.

Authors:  G Webster Ross; Helen Petrovitch; Robert D Abbott; Caroline M Tanner; Jordan Popper; Kamal Masaki; Lenore Launer; Lon R White
Journal:  Ann Neurol       Date:  2008-02       Impact factor: 10.422

3.  Even cognitively well-functioning adults are unaware of their olfactory dysfunction: Implications for ENT clinicians and researchers.

Authors:  Eike Wehling; Astri J Lundervold; Thomas Espeset; Ivar Reinvang; Annika Bramerson; Steven Nordin
Journal:  Rhinology       Date:  2015-03       Impact factor: 3.681

4.  Prevalence of olfactory impairment in older adults.

Authors:  Claire Murphy; Carla R Schubert; Karen J Cruickshanks; Barbara E K Klein; Ronald Klein; David M Nondahl
Journal:  JAMA       Date:  2002-11-13       Impact factor: 56.272

5.  Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder.

Authors:  Alex Iranzo; Mónica Serradell; Isabel Vilaseca; Francesc Valldeoriola; Manel Salamero; Cristina Molina; Joan Santamaria; Eduardo Tolosa
Journal:  Parkinsonism Relat Disord       Date:  2013-03-23       Impact factor: 4.891

6.  Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease.

Authors:  J P Kesslak; C W Cotman; H C Chui; S Van den Noort; H Fang; R Pfeffer; G Lynch
Journal:  Neurobiol Aging       Date:  1988 Jul-Aug       Impact factor: 4.673

7.  Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.

Authors:  R L Doty; M B Stern; C Pfeiffer; S M Gollomp; H I Hurtig
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

Review 10.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

View more
  1 in total

1.  Olfactory Testing in Parkinson Disease and REM Behavior Disorder: A Machine Learning Approach.

Authors:  Christine Lo; Siddharth Arora; Yoav Ben-Shlomo; Thomas R Barber; Michael Lawton; Johannes C Klein; Sofia Kanavou; Annette Janzen; Elisabeth Sittig; Wolfgang H Oertel; Donald G Grosset; Michele T Hu
Journal:  Neurology       Date:  2021-02-24       Impact factor: 9.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.